Centuria Healthcare

Andrew Hemming, Managing Director of Centuria Healthcare, explains why healthcare assets have been resilient, especially throughout the COVID-19 affected period.

This video was issued on 11 August 2020 by Centuria Property Funds No. 2 Limited (ABN 38 133 363 185, AFSL No. 340 304) (‘CPF2L’) and Centuria Healthcare Pty Limited (ABN 74 001 477 505) (‘CHPL’). CPF2L, a wholly owned subsidiary of the Centuria Capital Group (ASX: CNI), is the Responsible Entity for the Centuria Healthcare Property Fund (ARSN 638 821 360) (‘Fund’). CPF2L expects to issue a Product Disclosure Statement (PDS) for the Fund on or around 24 August 2020. The advertised starting distribution rate of 5.75%p.a. is calculated on an application price of $1.000 per unit and is therefore subject to change. The advertised starting distribution rate is from October 2020. The advertised starting distribution rate is not a forecast, and merely represents the distribution rate the Fund intends to distribute from October 2020. It is therefore predictive in nature and is subject to assumptions (including the assumption that the pipeline assets will be acquired by the Fund), risks and circumstances (both known and unknown) outside of the control of CHPL and CPF2L. The actual returns may differ from the starting distribution rate. CHPL and CPF2L do not guarantee the performance of the Fund, the repayment of capital or any income or capital return. The actual distributions paid in cents per unit will be updated on a monthly basis and made available at centuria.com.au/CHPF. The information is of a general nature only and has not been prepared taking into account your particular investment objectives, financial situation and needs. You should read the PDS and assess whether any advice is appropriate before making any investment decision. You should also consider seeking the assistance of a professional investment adviser. Past performance is not a reliable indicator of future performance.  CA-Corp-17/08/20-01162.